Navigation Links
Scott Garrett Joins Water Street Healthcare Partners
Date:4/12/2011

CHICAGO, April 12, 2011 /PRNewswire/ -- Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care, announced today that Scott Garrett has joined the firm as an operating partner.  Mr. Garrett, 61, the former chairman, president and chief executive officer of Beckman Coulter, Inc., brings to Water Street more than 35 years of experience leading health care businesses ranging from diagnostics and life sciences to medical products and services.  He is the most recent addition to Water Street's team of senior executives and investment professionals focused on expanding and building value in the firm's companies specializing in life sciences, medical devices, distribution and health care services.

During his 35-year career, Mr. Garrett has completed more than 40 mergers and acquisitions to build shareholder value across a number of global health care businesses.  He began his career in research and development at Baxter International, where he was awarded several patents.  He was promoted to senior staff and general management positions in the U.S. and Europe, before being appointed group vice president and CEO of Baxter's global laboratory products subsidiary.  Mr. Garrett led the buyout of that business, becoming chairman, president and CEO of Dade Behring.  He and his team built Dade Behring into one of the world's largest clinical diagnostics companies.  More recently, Mr. Garrett led Beckman Coulter through an eight-year-more period of value creation establishing the company as a leader in biomedical testing.  Previously, he founded Garrett Capital Advisors and partnered with members of the Water Street team to build a portfolio of private companies in the medical device and life sciences industries.

"Water Street's unique business model brings together experienced health care and financial executives providing its companies with strategic insight and operational know-how.  This focused approach creates long-term, sustainable value," said Mr. Garrett.  "In the years since I first partnered with the Water Street team, they have achieved an impressive track record, building market-leading companies across attractive sectors of health care.  I am excited to be part of the team, and look forward to helping them identify and grow many more excellent companies in the future."

Mr. Garrett is highly regarded for his contributions to the health care industry.  He has served as an advocate of the medical device and diagnostics industry with a combined tenure of 10 years on the AdvaMed board of directors.  He was also instrumental in the recent founding of AdvaMed Dx, focused on the in vitro diagnostics industry.  Mr. Garrett augments Water Street's team of health care executives, which includes:

  • Dominick Arena, former CEO, Medex
  • Jim Connelly, former president and COO, Caremark International
  • Steve Cosler, former president and CEO, Priority Healthcare Corporation
  • Al Heller, former CEO, American Pharmaceutical Partners Inc.
  • Curt Selquist, former company group chairman, Johnson & Johnson
  • Steve Shulman, former CEO, Magellan Health Services, Inc. and Prudential Healthcare
  • Kevin Swan, former president & CEO, Griffith Micro Science/Sterigenics

"We are honored that Scott chose Water Street as the firm he wants to partner with long-term," said Tim Dugan, managing partner, Water Street.  "He exemplifies the key attributes of our team members – strategic, results-oriented, high ethical standards and committed to value creation.  Our operating partners' deep health care expertise and network of contacts contribute significantly to growing and building value in our companies.  The depth and breadth of their expertise continues to be an important factor that sets Water Street apart."

About Water Street Healthcare Partners

Water Street Healthcare Partners is a strategic private equity firm focused exclusively on health care.  The firm has a strong record of building market-leading companies across key growth sectors in health care.  It has worked with some of the world's leading health care companies on its investments including Gentiva, Johnson & Johnson, Medtronic and Smith & Nephew.  Water Street's team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses.  The firm is headquartered in Chicago.  For more information about Water Street, visit www.wshp.com.


'/>"/>
SOURCE Water Street Healthcare Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Innovation Set to Revolutionise Spray Technology - Used to Protect Against the Scottish Biting Midge & Help Fight MRSA in the NHS
2. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
3. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
4. MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care
5. United States Recognizes Leading Scottish Scientist for Disease Research
6. SIRO Group Appoints Scott L. Spector as President, Strategic Operations, for its European Business
7. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
8. Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing
9. Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation
10. TGen and Scottsdale Healthcare researchers discover microRNA role in brain metastasis
11. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):